Game-Changing Study Confirms Medical Cannabis Helps Cancer Patients: ‘We Found Overwhelming Scientific Consensus’
In a milestone moment for cannabis research, Frontiers in Oncology published the most expansive meta-analysis ever conducted on medical cannabis and cancer. The study was led by Cancer Playbook, a platform powered by the Whole Health Oncology Institute (WHOI) and reviewed more than 10,000 peer-reviewed studies—more than ten times the size of any previous review in this space.
“We expected controversy. What we found was overwhelming scientific consensus,” said Ryan Castle, head of research at WHOI. “This is one of the clearest, most dramatic validations of medical cannabis in cancer care that the scientific community has ever seen.”
The full review, available here, analyzed 39,767 data points from 10,641 studies and used advanced sentiment analysis tools to quantify consensus across medical literature.
A 3:1 Consensus In Favor Of Cannabis
For every one study suggesting cannabis did not work, three others showed it did.
That 3:1 ratio, especially in a field as cautious as oncology, places cannabis on par with—if not ahead of—many FDA-approved drugs. The report found that cannabis consistently showed positive …